Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus.

NCT01500265 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT01500265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus.
Lead sponsor
University Hospital, Limoges
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
December 31, 2015
Enrollment
216 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, renal failure with tubular necrosis